Diagnostic criteria according to Alarcón-Segovia and Villareal |
1. Serologic criterion: Positive antibodies to U1 RNP antibodies at a titer ≥1:1600 2. Clinical criteria: 1) Edema of the hands 2) Synovitis 3) Myositis 4) Raynaud phenomenon 5) Sclerodactyly |
Diagnosis of MCTD: Fulfilled serologic criterion and ≥3 of the clinical criteria (coexisting edema of the hands, Raynaud phenomenon, and Sclerodactyly require an additional fulfillment of the criteria 2b or 2c). |
Diagnostic criteria according to Kasukawa et al |
1. Common symptoms: 1) Raynaud phenomenon 2) Swollen fingers or hands 2. Positive antibodies to U1 RNP 3. Mixed findings: 1) SLE-like findings: a) Polyarthritis b) Lymphadenopathy c) Facial erythema d) Pericarditis or pleuritis e) Leukopenia or thrombocytopenia 2) SSc-like symptoms: a) Sclerodactyly b) Pulmonary fibrosis, restrictive pattern on pulmonary function tests, or reduced DLCO c) Hypomotility or esophageal dilation 3) Polymyositis-like symptoms: a) Muscle weakness b) Raised serum creatine kinase levels c) Myogenic pattern on electromyography |
Diagnosis of MCTD: Presence of ≥1 common symptom, serologic criterion, and ≥1 from each group of the mixed findings (1, 2, 3). |
Adapted from (1) Alarcón-Segovia D, Villarreal M. Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R, Sharp GC, eds. Mixed connective tissue disease and anti-nuclear antibodies. Amsterdam: Elsevier Science Publishers B.V. (Biomedical Division); 1987: 33-40; (2) Kasukawa R, Tojo T, Miyawaki S. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC, eds. Mixed connective tissue disease and anti-nuclear antibodies. Amsterdam: Elsevier Science Publishers B.V. (Biomedical Division); 1987: 41-7. |
DLCO, carbon monoxide diffusing capacity of the lungs; MCTD, mixed connective tissue disease; RNP, ribonucleoprotein; SLE, systemic lupus erythematosus; SSc, systemic sclerosis. |